Vaccination Recommendations for MS Patients Starting Disease-Modifying Therapy
Yes, you should receive updated meningococcal and pneumococcal vaccines before starting your DMT, even though you received childhood vaccines, because many disease-modifying therapies for MS significantly increase your risk of invasive infections and require enhanced vaccination protection.
Critical Meningococcal Vaccination Updates Needed
You already received MenB before college, but you need to verify your MenACWY (quadrivalent) vaccination status and timing. According to current ACIP guidelines, if you received your last MenACWY dose before age 16, you need a booster dose now at age 30 1. Standard adolescent vaccination schedules recommend boosters at age 16-18, and since you're starting immunosuppressive therapy, this becomes even more critical.
Specific Meningococcal Recommendations:
- MenACWY: If your last dose was before age 16, get a single booster dose now 1
- MenB: Your pre-college MenB series may need updating depending on which DMT you'll receive. For high-risk immunosuppressed patients, MenB boosters are recommended 1 year after primary series, then every 2-3 years 1
Important timing consideration: Ideally complete meningococcal vaccination at least 2 weeks before starting your DMT 2, 3. If treatment must start urgently, vaccinate immediately and consider antibiotic prophylaxis during the initial treatment period 4.
Pneumococcal Vaccination - Essential Update Required
You absolutely need pneumococcal vaccination now, regardless of childhood vaccines. The childhood pneumococcal series (PCV7 or PCV13) you received does not provide adequate protection for immunocompromised adults.
Recommended Pneumococcal Schedule:
- PCV13 or PCV15 first (if not previously received as adult)
- PPSV23 at least 8 weeks later 5
- Second PPSV23 dose 5 years after the first 5
This two-vaccine approach is specifically recommended for immunocompromised patients and provides broader serotype coverage than childhood vaccines alone.
Additional Essential Vaccines Before DMT
High Priority (Complete Before DMT Start):
- Influenza vaccine (annually, every year regardless of DMT) 3, 6
- Haemophilus influenzae type B (Hib) - Often overlooked but recommended for immunocompromised patients 2
- Hepatitis B series (if not previously completed) - Important given infection risks on immunosuppression 7
Verify and Update if Needed:
- MMR (Measles, Mumps, Rubella) - Check antibody titers; if non-immune, must vaccinate before DMT as this is a live vaccine contraindicated once immunosuppressed 3, 6
- Varicella (chickenpox) - Same as MMR; check immunity and vaccinate before DMT if needed 3
- Tdap - You mentioned being up-to-date, which is good; boosters every 10 years
Consider Based on Risk Factors:
- Hepatitis A - If traveling or other risk factors
- HPV - You received this, which is excellent
- Shingles (Recombinant Zoster Vaccine/Shingrix) - Generally recommended age 50+, but consider earlier for immunosuppressed patients; this is an inactivated vaccine safe on DMTs 6
Critical Timing Principles
The type of DMT you'll receive dramatically affects vaccination strategy:
For B-cell Depleting Therapies (Ocrelizumab, Rituximab, Ofatumumab):
- Complete ALL vaccinations at least 4-6 weeks before first infusion 6, 8
- These drugs severely impair antibody responses to vaccines for 6-12+ months
- Vaccination during treatment provides minimal protection 9, 6
For S1P Modulators (Fingolimod, Siponimod, Ozanimod):
- Vaccinate at least 2 weeks before starting 2
- Reduced but present vaccine responses on therapy
- Inactivated vaccines can be given during treatment if necessary 6
For Other DMTs (Natalizumab, Dimethyl Fumarate, Teriflunomide):
- Less impact on vaccine responses
- Still preferable to vaccinate before starting when possible 6
For Cladribine:
- Unique opportunity: can vaccinate effectively between treatment courses and after completion 6
Practical Implementation Strategy
Discuss this specific timeline with your PCP:
- Week 0: Blood work to check MMR, varicella immunity
- Week 1: Administer all inactivated vaccines that can be given simultaneously:
- MenACWY (if needed)
- MenB booster (if indicated by DMT type)
- PCV13/PCV15
- Hib
- Influenza (if season appropriate)
- Hepatitis B (start series if needed)
- Week 2-3: If MMR or varicella needed (live vaccines), administer at least 4 weeks before DMT start 2, 3
- Week 4+: Can safely start DMT
- Week 12: PPSV23 (8 weeks after PCV)
A recent real-world study demonstrated this approach is feasible, with median vaccination completion time of 27 days without delaying DMT initiation 2.
Common Pitfalls to Avoid
- Don't assume childhood vaccines provide lifelong protection - Many wane, and immunosuppression increases infection risk
- Don't delay vaccination "to see how the disease progresses" - Once on certain DMTs, vaccine responses are severely compromised 9, 6
- Don't receive live vaccines after starting immunosuppressive DMTs - Contraindicated and potentially dangerous 3, 6
- Don't skip annual influenza vaccination - Recommended regardless of DMT type 3
Safety Reassurance
Extensive evidence confirms vaccinations do not trigger MS relapses or worsen disease activity 9, 3. A systematic review of 133 studies found that vaccinations, particularly inactivated vaccines, do not aggravate MS or increase relapse probability 9. Real-world data from 195 MS patients showed no increase in clinical or radiological activity 3-6 months after vaccination 2.
The risk of NOT vaccinating far exceeds any theoretical vaccine risks, especially given that infections themselves are known MS relapse triggers 3, 6.